This compound is a protected nucleotide derivative used as an intermediate in the synthesis of modified oligonucleotides. It features a 2'-fluoro-2'-deoxyuridine core with a 5'-O-dimethoxytrityl protecting group and a 3'-O-(diisopropylamino-2-cyanoethoxyphosphanyl) moiety, facilitating its incorporation into nucleic acid research.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 146954-75-8
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
RNA synthesis phosphoramidite building block
2'-propargyl U amidite
RNA synthesis phosphoramidite building block
RU Phosphoramidite
RNA oligonucleotide synthesis building block
Methyl 16-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-2-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-3-yl]oxyhexadecanoate
phosphoramidite building block for oligonucleotide synthesis
Mirogabalin Impurities N75
pharmaceutical impurity reference standard
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-6-{[(prop-2-en-1-yloxy)carbonyl]amino}hexanoic acid
Protected amino acid for peptide synthesis
Dapagliflozin Impurity 9
Pharmaceutical impurity reference standard
Tert-butyl N-(chlorosulfonyl)carbamate
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
HQHQPAYRJJMYQX-DJTPZYMWSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@@H]1[C@H](O[C@H]([C@@H]1F)N2C=CC(=O)NC2=O)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC